insights_auto
Miks on AZN tõusnud? 4,32%?
Uurige põhjalikumaltchevron_right
AZN:NYSE
AstraZeneca
162,55 $
arrow_upward
+4,32%(+6,73) 1 p
14. okt, 13:44:12 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse AZN põhistatistika genereerimine…
Ava
158,71 $
Kõrge
162,67 $
Madal
158,31 $
Turu kapit.
255,08 mld
Keskm. maht
2,91 mln
Maht
1,62 mln
Dividend
1,98%
Kvartaalne dividend
0,81 $
Dividendikuupäev
6. aug 2026
Hinna ja tulu suhe
24,30
52 näd kõrgeim
212,71 $
52 näd madalaim
80,48 $
Aktsiatulu
6,69 $
Beeta
0,30
Käibivad aktsiad
1,55 mld
Töötajate arv
96 tuh
Ava
158,71 $
Kõrge
162,67 $
Madal
158,31 $
Turu kapit.
255,08 mld
Keskm. maht
2,91 mln
Maht
1,62 mln
Dividend
1,98%
Kvartaalne dividend
0,81 $
Dividendikuupäev
6. aug 2026
Hinna ja tulu suhe
24,30
52 näd kõrgeim
212,71 $
52 näd madalaim
80,48 $
Aktsiatulu
6,69 $
Beeta
0,30
Käibivad aktsiad
1,55 mld
Töötajate arv
96 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
TipRanks
·
1 tunni eest
AstraZeneca’s LAZURE Trial Signals Next Step in Cholesterol Treatment
Timothy Sykes
·
1 tunni eest
AstraZeneca Stock Draws Bullish Targets As Oncology Deals Pile Up
StocksToTrade
·
1 tunni eest
AstraZeneca PLC Stock Draws Upgrades As Oncology Deals Accelerate
Quiver Quantitative
·
2 tunni eest
Why AstraZeneca (AZN) Stock Is Up Today
Profiil
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Teave üksuse AstraZeneca kohta
TegevjuhtPascal Soriot
Töötajad96,1 tuh
Asutatud6. apr 1999
PeakontoridCambridge, Cambridgeshire, Suurbritannia
Sektor-
Veebisaitastrazeneca.com